Log in
Enquire now
‌

US Patent 11359018 Anti-PD-1 antibodies and compositions

Patent 11359018 was granted and assigned to Symphogen on June, 2022 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Is a
Patent
Patent
0
Current Assignee
‌
Symphogen
0
Date Filed
November 17, 2017
0
Date of Patent
June 14, 2022
0
Patent Applicant
‌
Symphogen
0
Patent Application Number
16461957
0
Patent Citations
‌
US Patent 11034765 Anti-PD-1 antibodies and compositions
Patent Citations Received
‌
US Patent 11939380 Combination therapies targeting PD-1, TIM-3, and LAG-3
0
Patent Inventor Names
Camilla Frohlich
0
Vikram Kjoller Bhatia
0
Torben Gjetting
0
Thomas Bouquin
0
Monika Gad
0
Klaus Koefoed
0
Johan Lantto
0
Gunther Roland Galler
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
11359018
0
Patent Primary Examiner
‌
Zachary C Howard
0
CPC Code
‌
C07K 16/2818
0
‌
C07K 14/70521
0
‌
A61K 39/3955
0

Find more entities like US Patent 11359018 Anti-PD-1 antibodies and compositions

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.